Geneva Capital Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$61M Buy
1,185,099
+86,380
+8% +$4.44M 1.02% 35
2025
Q1
$64.4M Buy
1,098,719
+8,784
+0.8% +$515K 1.2% 27
2024
Q4
$78.5M Sell
1,089,935
-14,375
-1% -$1.04M 1.36% 26
2024
Q3
$88.3M Buy
1,104,310
+17,114
+2% +$1.37M 1.47% 21
2024
Q2
$77.9M Buy
1,087,196
+7,183
+0.7% +$515K 1.42% 23
2024
Q1
$76M Buy
1,080,013
+757
+0.1% +$53.3K 1.34% 26
2023
Q4
$83.3M Buy
1,079,256
+9,322
+0.9% +$719K 1.57% 22
2023
Q3
$72.8M Sell
1,069,934
-1,583
-0.1% -$108K 1.53% 25
2023
Q2
$87.5M Buy
1,071,517
+1,260
+0.1% +$103K 1.72% 16
2023
Q1
$79.4M Buy
1,070,257
+10,757
+1% +$798K 1.62% 18
2022
Q4
$87.8M Sell
1,059,500
-6,072
-0.6% -$503K 1.97% 11
2022
Q3
$75.7M Buy
1,065,572
+40,864
+4% +$2.9M 1.75% 13
2022
Q2
$88.8M Sell
1,024,708
-5,900
-0.6% -$511K 2.04% 8
2022
Q1
$112M Sell
1,030,608
-3,100
-0.3% -$336K 2.16% 4
2021
Q4
$134M Sell
1,033,708
-23,520
-2% -$3.04M 2.16% 6
2021
Q3
$128M Sell
1,057,228
-354,696
-25% -$43M 2.17% 5
2021
Q2
$159M Sell
1,411,924
-21,772
-2% -$2.45M 2.59% 2
2021
Q1
$137M Sell
1,433,696
-178,136
-11% -$17M 2.34% 2
2020
Q4
$128M Buy
1,611,832
+46,292
+3% +$3.67M 2.17% 5
2020
Q3
$97M Buy
1,565,540
+35,492
+2% +$2.2M 2% 7
2020
Q2
$101M Buy
1,530,048
+41,996
+3% +$2.77M 2.19% 7
2020
Q1
$70.5M Buy
+1,488,052
New +$70.5M 2.01% 6
2014
Q3
$19.1M Sell
814,772
-18,448
-2% -$431K 0.56% 68
2014
Q2
$19.3M Buy
833,220
+53,156
+7% +$1.23M 0.47% 66
2014
Q1
$16.6M Buy
780,064
+98,136
+14% +$2.09M 0.39% 73
2013
Q4
$16.1M Buy
681,928
+152,424
+29% +$3.61M 0.37% 78
2013
Q3
$10.6M Buy
529,504
+69,776
+15% +$1.4M 0.25% 94
2013
Q2
$7.94M Buy
+459,728
New +$7.94M 0.16% 95